A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism-Reference-Cited by-同舟云学术

A regression model to predict warfarin dose from clinical variables and polymorphisms in CYP2C9, CYP4F2, and VKORC1: Derivation in a sample with predominantly a history of venous thromboembolism

Published:2010-06 Issue:6 Volume:125 Page:e259-e264
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Wells P.S.,Majeed H.,Kassem S.,Langlois N.,Gin B.,Clermont J.,Taljaard M.

Funder

Heart and Stroke Foundation of Canada

Publisher

Elsevier BV

Subject

Hematology

Reference34 articles.

1. Effect of long-term oral anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction;Lancet,1994

2. Optimal oral anticoagulant therapy in patients with mechanical heart valves;Cannegieter;N Engl J Med,1995

3. Risk factors for complications of chronic anticoagulation;Fihn;Ann Intern Med,1993

4. Bleeding during antithrombotic therapy in patients with atrial fibrillation;Arch Intern Med,1996

5. Adjusted-dose warfarin versus low-intensity, fixed dose warfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial;Lancet,1996

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement;Medicine;2022-07-22

2. Evaluation of the impact of body mass index on venous thromboembolism risk factors;PLOS ONE;2020-07-09

3. Coagulation and Anticoagulants;Precision Anticoagulation Medicine;2019-12-31

4. Significance of CYP4F2 polymorphism on oral anticoagulation therapy with acenocoumarol in South Indian patients with mechanical heart valves;Meta Gene;2019-06

5. Effect of CYP 4F2 , VKORC 1 , and CYP 2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals;Clinical Pharmacology & Therapeutics;2019-02-17